This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

UPDATE: Commercial Operations Webinar Series: Enabling The New Marketing Model

SANTA MONICA, Calif., Nov. 15, 2012 /PRNewswire/ -- UBM Canon, Pharmalive.com, and Appature, a leading software-as-a-service (SaaS) provider for marketers, are proud to kick-off their Commercial Operations: Enabling the New Marketing Model Webinar Series. The first in the series, sponsored by Appature, will focus specifically on The End to End Marketing Ecosystem and will offer an in-depth analysis and discussion from experts in the industry.

(Logo: http://photos.prnewswire.com/prnh/20121115/LA14527LOGO)

(Logo: http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

This webinar series will focus on how Commercial Operations is evolving critical skills and capabilities to enable a new, more complex era of data-driven marketing.  While the technologies and processes supporting the sales force have been robust and mature for many years, the analogous capabilities for the marketing function are still emerging.  This is challenging commercial operations teams to quickly build new competencies in order to function as the executional nerve center connecting all marketing channels and touch points.  Throughout this series, experts, thinkers and practitioners across industry disciplines will share the critical steps and success factors for becoming a strategic commercial operations professional in the new era.

The first installment will address:

  • The key elements within the marketing ecosystem
  • Making sense of the proliferation of channels and data
  • Essential connections to be made in both systems and organizational functions
  • Assessing gaps in the ecosystem that may impact customer experience, campaign optimization and ROI

This Webcast will feature presentations by Erik Prince, Marketing Solutions Architect, Appature, Aaron Uydess, Associate Director – Digital Strategy, Novo Nordisk, and Pratap Khedkar, Managing Principal, ZS Associates.   The Webcast concludes with a live Q&A session moderated by Chris Truelove, Director of Content, Med Ad News.

This installment of the series will take place on Wednesday, December 12 th at 1:00 p.m. ET ( 12:00 p.m. CT, 10:00 a.m. PT). The event will be archived for one year on the website.  Register only once, and have access to each remaining webinar in the series.  For more information or to register for the event, please click here.

About Appature, Inc.

Appature, Inc. is a Seattle‐based technology company that provides a "surprisingly simple" cloud‐based relationship marketing software platform, Appature Nexus, designed exclusively for healthcare and life science companies. Appature Nexus enables marketers to deepen brand relationships and drive share growth with a platform that integrates the marketing database, campaign management tool and analytics suite into one easy‐to‐use tool. Leaders in the pharmaceutical, medical device and consumer healthcare industries rely on Appature to realize the full potential of their customer relationships. Please visit www.appature.com.

About UBM Canon

UBM Canon, the leading B-to-B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM (UBM.L) a global provider of media and information services for professional B2B communities and markets.

About Med Ad News

The pharmaceutical industry's publication of record for 30 years, Med Ad News provides broad coverage and incisive analysis of the issues, events, trends, and strategies shaping pharmaceutical business, marketing, and sales. More than 16,500 readers – comprising corporate executives, marketing, sales, and product managers – receive Med Ad News 12 times per year. Med Ad News is a publication of UBM Canon Pharmaceutical Media Group. More info visit www.pharmalive.com.

SOURCE UBM Canon

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs